IPI APP by SECURE SYSTEM BYTES
Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI in: Journal of the National Comprehensive Cancer Network Volume 13 Issue 12 (2015)
Novel prognostic scoring system for diffuse large B-cell lymphoma
Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter? | Journal of Nuclear Medicine
Immunohistochemical Distinction Between Diffuse Large B-Cell... | Download Table
Frontiers | A Novel Prognostic Score Including the CD4/CD8 for AIDS-Related Lymphoma
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
Prephase rituximab/prednisone therapy and aging-related, proinflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma | Haematologica
Diffuse large B cell lymphoma: Outlook, stages, treatment
Follicular Lymphoma International Prognostic Index (FLIPI). Online calculator | ClinCaseQuest
Diffuse Large B-cell Lymphoma Prognosis Calculator
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
Comparative molecular cell-of-origin classification of diffuse large B-cell lymphoma based on liquid and tissue biopsies | Translational Medicine Communications | Full Text
Diffuse Large B-Cell Lymphoma Prognosis (R-IPI) | QxMD
Overall survival curves of patients with primary gastric diffuse large... | Download Scientific Diagram
Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials - Annals of Oncology
Gray Zone Lymphoma (GZL) with Features Intermediate between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): A Large Retrospective. - ppt download
A modified prognostic model in patients with diffuse large B‑cell lymphoma treated with immunochemotherapy
R/R International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology
A model to predict the prognosis of diffuse large B-cell lymphoma based on ultrasound images | Scientific Reports
Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online Library
Prediction of Prognosis for Patients with Diffuse Large B-Cell Lymphoma Refractory to or in First Relapse After Initial R-CHOP Therapy: A Single-Institution Study | Anticancer Research
Survival Rates and Factors That Affect Prognosis (Outlook) for Non-Hodgkin Lymphoma
